We are live on ! Find out more
NVACR

NorthView Acquisition Corporation Rights
NVACR

Delisted

NVACR was delisted on the 26th of December, 2024.

Back to rankings

33 hedge funds and large institutions have $652K invested in NorthView Acquisition Corporation Rights in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

3% less funds holding

Funds holding: 34 → 33 (-1)

53% less capital invested

Capital invested by funds: $1.39M → $652K (-$736K)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
33
Holders Change
-1
Holders Change %
-2.94%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CS
Clear Street
New York
+$2.77K
2
TSS
Two Sigma Securities
New York
+$1.03K

Top Sellers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
-$52.3K
2
SCM
Shaolin Capital Management
Florida
-$11.5K
3
SOA
Sea Otter Advisors
Florida
-$3.72K
4
CAC
Cowen and Company
New York
-$52
5
BI
Bulldog Investors
New Jersey
-$34
Name Holding Trade Value Shares
Change 		Change in
Stake
MP
1
Mangrove Partners
Connecticut
$76.7K – – –
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$66.8K – – –
SCM
3
Saba Capital Management
New York
$60.3K – – –
PL
4
Parkwood LLC
Ohio
$51K – – –
BFM
5
Boothbay Fund Management
New York
$46K – – –
ASM
6
ATW SPAC Management
New York
$46K – – –
YCM
7
Yakira Capital Management
Connecticut
$43.1K – – –
CAC
8
Cowen and Company
New York
$34.3K -$52 -675 -0.1%
HCM
9
Highbridge Capital Management
New York
$25.6K – – –
AA
10
AQR Arbitrage
Connecticut
$22.6K – – –
HCM
11
Heights Capital Management
California
$22.4K +$33.5K +437,419 New
CSD
12
Clear Street Derivatives
New York
$20.3K – – –
CS
13
Clear Street
New York
$17.2K +$2.77K +36,166 +12%
SCM
14
Shaolin Capital Management
Florida
$15.3K -$11.5K -150,000 -33%
RCM
15
Rivernorth Capital Management
Florida
$12.8K – – –
WA
16
Whitebox Advisors
Minnesota
$12.8K – – –
WAM
17
Wolverine Asset Management
Illinois
$12.4K – – –
MTCM
18
Mint Tower Capital Management
Netherlands
$10K – – –
SIA
19
SkyView Investment Advisors
New Jersey
$10K – – –
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$7.67K – – –
GF
21
Gabelli Funds
New York
$7.39K – – –
PC
22
Periscope Capital
Ontario, Canada
$5.94K -$52.3K -683,100 -85%
GCIA
23
Gabelli & Co Investment Advisers
New York
$5.38K – – –
HIM
24
HGC Investment Management
Ontario, Canada
$5.11K – – –
BCM
25
Bluefin Capital Management
New York
$3.07K – – –
1
2

NVACR Hedge Fund Activity: Q3 2024 in Review

33 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in NorthView Acquisition Corporation Rights (NVACR) for Q3 2024, worth a combined $652K — down 53% from $1.39M a quarter earlier.

Fund positioning in NVACR was balanced in Q3 2024: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 4 trimmed.

The largest buyer was Clear Street, adding an estimated $2.77K. The largest seller was Periscope Capital, cutting an estimated $52.3K.

  • 33 institutional investors held NorthView Acquisition Corporation Rights (NVACR) as of Q3 2024, down from 34 in Q2 2024.
  • Funds reported $652K of NorthView Acquisition Corporation Rights stock for Q3 2024, down 53% quarter-over-quarter.
  • 2 funds opened new NorthView Acquisition Corporation Rights positions in Q3 2024 and 2 closed out, a net change of 0 holders.
  • The largest NorthView Acquisition Corporation Rights buyer in Q3 2024 was Clear Street, an estimated $2.77K added.
  • The largest NorthView Acquisition Corporation Rights seller in Q3 2024 was Periscope Capital, an estimated $52.3K sold.

Based on aggregated 13F filings for Q3 2024.